An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Sildenafil (Primary)
- Indications Cardiovascular disorders; Erectile dysfunction; Female infertility; Pulmonary hypertension
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Oct 2009 Actual initiation date (Aug 2009) added as reported by ClinicalTrials.gov.
- 07 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2009 Planned initiation date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov